Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Jan 7, 2009

Premium
The United States Patent and Trademark Office said this week that John Doll, the acting deputy under secretary of commerce for intellectual property, will become interim director of the organization when current director Jon Dudas leaves the position next week.
 
The USPTO said Dudas will serve as director until January 20, when President-Elect Barack Obama’s administration takes over. Doll will serve as interim director of the USPTO until a new permanent director is appointed.
 
Most recently, Doll was the commissioner for patents, responsible for all aspects of the patent-granting process for the US. Previously, Doll served as deputy commissioner for patent resources and planning, and on a detail assignment as special assistant to Dudas.
 

 
Life sciences venture capital firm Clarus Ventures said this week that Emmett Cunningham has been promoted to partner and Scott Requadt to transactional partner.
 
Cunningham joined Clarus in 2006 and represents the firm on the board of SARcode and as a board observer at FerroKin, Pearl, Taligen, and Zogenix. He is also a member of the scientific advisory boards of ESBATech and CoMentis. He joined Clarus from Eyetech Pharmaceuticals, where he was senior vice president of medical strategy.
 
Requadt joined Clarus in 2005 and represents the firm on the board of TyRx Pharma and as a board observer at Biolex, Oxford Immunotec, Link Medicine, and Variation. He joined Clarus from TransForm Pharmaceuticals after the company was sold to Johnson & Johnson in 2005. Prior to TransForm, Requadt was an attorney specializing in mergers and acquisitions at the New York-based law firm of Davis Polk & Wardwell.
 

 
Vicki Chandler, director of the University of Arizona's Bio5 Institute, is leaving her post to become chief program officer, science, with the Gordon and Betty Moore Foundation in San Francisco. The new position is effective Feb. 17.
 
Chandler will run the foundation's science program, which promotes collaboration across scientific fields. Chandler will also continue to devote about 20 percent of her time on her research program at the University of Arizona, including her involvement in the iPlant Collaborative, a project administered by Bio5 and funded through a $50 million grant from the National Science Foundation.
 
A professor in the departments of plant sciences and molecular and cellular biology, Chandler holds the Weiler Endowed Chair for Excellence in Agriculture and Life Sciences, a position she will retain along with her UA research activities.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.